Logo 6 a1e69dad97a22b9caa5aa6c606f6ea7f9e9b8c4d0352141ae8a7e9bed5512ee3
  • Antibodies
  • Assays/Kits
  • Proteins/Peptides
  • siRNAs/Functional Genomics
  • Biochemicals
  • cDNA Clones
  • Cell/Tissue/Blood Products
  • Genes
  • Images

Gavestinel

Name Gavestinel
Supplier R&D Systems
Catalog 2348
Prices $169.00, $705.00
Sizes 10 mg, 50 mg
Cas Number 153436-38-5
Chemical Name 4,6-Dichloro-3-[(1E)-3-oxo-3-(phenylamino)-1-propenyl]-1H-indole-2-carboxylicacidsodiumsalt
Formula C18H11Cl2N2O3Na
Molecular Weight 397.19
Purity >98%
Supplier Page Shop

Product References

Substituted indole-2-carboxylates as in vivo potent antagonists acting as the - Substituted indole-2-carboxylates as in vivo potent antagonists acting as the

Di Fabio R, Capelli AM, Conti N, Cugola A, Donati D, Feriani A, Gastaldi P, Gaviraghi G, Hewkin CT, Micheli F, Missio A, Mugnaini M, Pecunioso A, Quaglia AM, Ratti E, Rossi L, Tedesco G, Trist DG, Reggiani A. J Med Chem. 1997 Mar 14;40(6):841-50.

Receptor binding characteristics of the novel NMDA receptor glycine site - Receptor binding characteristics of the novel NMDA receptor glycine site

Mugnaini M, Dal Forno G, Corsi M, Bunnemann B. Eur J Pharmacol. 2000 Mar 17;391(3):233-41.

Pharmacokinetics, metabolism and excretion of the glycine antagonist GV150526A in - Pharmacokinetics, metabolism and excretion of the glycine antagonist GV150526A in

Kajbaf M, Barnaby RJ, Bottacini M, Bertolotti L, Ismail IM, Cholerton TJ, Pellegatti M. Xenobiotica. 2003 Apr;33(4):415-28.



Privacy
Terms
About us
Contact us

Copyright© 2025. All Rights Reserved